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Reactive oxygen speciess type-1 (HTLV-1) expresses an 87-amino acid protein named p13 that is targeted
to the inner mitochondrial membrane. Previous studies showed that a synthetic peptide spanning an alpha
helical domain of p13 alters mitochondrial membrane permeability to cations, resulting in swelling. The
present study examined the effects of full-length p13 on isolated, energized mitochondria. Results
demonstrated that p13 triggers an inward K+ current that leads to mitochondrial swelling and confers a
crescent-like morphology distinct from that caused by opening of the permeability transition pore. p13 also
induces depolarization, with a matching increase in respiratory chain activity, and augments production of
reactive oxygen species (ROS). These effects require an intact alpha helical domain and strictly depend on the
presence of K+ in the assay medium. The effects of p13 on ROS are mimicked by the K+ ionophore
valinomycin, while the protonophore FCCP decreases ROS, indicating that depolarization induced by K+ vs. H
+ currents has different effects on mitochondrial ROS production, possibly because of their opposite effects
on matrix pH (alkalinization and acidiﬁcation, respectively). The downstream consequences of p13-induced
mitochondrial K+ permeability are likely to have an important inﬂuence on the redox state and turnover of
HTLV-1-infected cells.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
HTLV-1 is a complex retrovirus that infects an estimated 10–20
millionpeopleworldwide. HTLV-1 is the causative agentof anaggressive
leukemia/lymphoma of mature CD4+ T-cells termed adult T-cell
leukemia/lymphoma (ATLL). ATLL arises in 1–5% of HTLV-1-infected
subjects after a latency period of several decades and is refractory to
current therapies. Despite intensive study, the molecular determinants
of ATLL are incompletely understood (reviewed in ref. [1]).
Studies of the viral factors governing HTLV-1 replication and
pathogenesis have been focused primarily on the transcriptional
activator Tax, which plays a critical role in cell immortalization
through its ability to deregulate the expression of a vast array ofOncologiche e Chirurgiche,
ova, Italy. Tel.: +39 049 821
ll rights reserved.cellular genes and interfere with cell cycle checkpoints (reviewed in
ref. [2]). Indeed, expression of Tax in mouse thymocytes is sufﬁcient
for induction of T-cell leukemia/lymphoma [3]. However, the contrast
between the powerful oncogenic properties of Tax and the low
prevalence and long latency of ATLL in HTLV-1-infected individuals
suggests the existence of mechanisms that limit the transforming/
pathogenic potential of the virus and favor life-long asymptomatic
persistence in the host.
Recent studies indicate that the viral accessory proteins p12, p21,
p30, HBZ and p13 also contribute to HTLV-1 replication and
pathogenesis (reviewed in ref. [4]). The present study is focused on
p13, an 87-amino acid accessory protein that is targeted to the inner
membrane of mitochondria (reviewed in ref. [5]). In the context of
cells, p13 induces mitochondrial fragmentation [6], slows down
proliferation [7,8], promotes apoptosis triggered by ceramide and
FasL [7,8], and interferes with tumor growth in experimental models
[8]. Although competent for replication in tissue culture, a p13-
knockout virus is incapable of establishing a persistent infection in a
rabbit experimental model [9]. Biophysical and biochemical analyses
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this region folds into an amphipathic α-helix upon exposure to
membrane-mimetic solutions and changes mitochondrial membrane
permeability to K+ [10]. The present study was aimed at further
understanding themechanism of p13 function through analyses of the
effects of full-length synthetic p13 on energized mitochondria.
2. Materials and methods
2.1. Peptide synthesis
Full-length wild-type p13 (87-mer) and p13-AL, which contains
alanines in the place of 4 arginines in the mitochondrial targeting
signal/amphipathic alpha helical domain [10], were synthesized by a
solid phase method on a polyethylene glycol polyacrylamide (PEGA)
resin functionalized with the acid labile linker 4-hydroxymethylphe-
noxyacetic acid (Novabiochem), using an Applied Biosystems Model
433 automated peptide synthesizer. The ﬂuoren-9-ylmethoxycarbo-
nyl (Fmoc) strategy [11] was used throughout the peptide chain
assembly, with 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium
hexaﬂuorophosphate (HBTU) and 1-hydroxybenzotriazole (HOBt) or
2-(1H-7-azabenzotriazol-1-yl)-1,1,3,3-tetramethyl uronium hexa-
ﬂuorophosphate methanaminium (HATU) employed as coupling re-
agents. The side-chain protecting groups were as follows: tert-butyl
for Ser, Thr, Tyr, Asp and Glu; tert-butyloxycarbonyl for Trp; trityl for
His, Cys, Asn and Gln; 2,2,4,6,7-pentamethyldihydrobenzofuran-5-
sulfonyl for Arg. Acetylation steps were carried out after every
coupling involving hydrophobic residues. Peptide cleavage was
performed by reacting the peptidyl-resins with 95% TFA/ethane-
dithiol for 3 h. Crude peptides were subsequently puriﬁed by two
serial chromatographic steps on preparative C8 and C18 reverse phase
HPLC columns. Molecular masses of the peptides were ascertained by
mass spectroscopy with direct infusion on a Waters-Micromass ZMD-
4000 Mass Spectrometer. The purity of the peptides was about 95% as
evaluated by analytical reverse phase HPLC.
2.2. Assays on isolated mitochondria
Liver mitochondria isolated from albino Wistar rats weighing
about 300 g were prepared by standard centrifugation techniques
exactly as previously described [12]. Brieﬂy, the liver was minced with
scissors in isotonic sucrose buffer (250 mM sucrose, 10 mM Tris–HCL,
0.1 mM EGTA-Tris, pH 7.4), washed with sucrose buffer to eliminate
residual blood, and then homogenized. The suspension was centri-
fuged at 600 ×g for 10 min to eliminate cells and large debris. The
supernatant was collected and centrifuged at 7000 ×g for 10 min to
pellet mitochondria, which were then resuspended in the same buffer
and centrifuged again at 7000 ×g for 10 min. The resulting washed
mitochondrial pellet was resuspended in a small volume of sucrose
buffer and assayed for protein content using the Biuret protein
determination assay.
To assess the uptake of p13 intomitochondria, the synthetic protein
(100 nM ﬁnal concentration) was added to a 1-mg aliquot of
mitochondria previously diluted in 2 ml KCl buffer, and incubated at
37 °C for 5 min. Mitochondria were then pelleted by centrifugation at
7000 ×g for 10 min, washed with 2 ml KCl buffer, and centrifuged
again. Resulting mitochondrial pellets were resuspended in sucrose-
HEPES buffer [10] and incubated on ice for 2 min after addition of
dimethyl sulfoxide (DMSO, 5%; serving as a control) or digitonin
(0.05% or 0.5%, prepared in DMSO). The suspensions were then
centrifuged at 17,500 ×g for 10 min and resulting supernatants and
pellets were solubilized and analyzed by SDS-PAGE followed by
electrotransfer to PVDFmembrane (HyBond P, GEHealthcare). Sodium
carbonate extraction assays were carried out as described previously
[10]. For this treatment, washed pellets of mitochondria loaded with
p13 were resuspended in 100 mM sodium carbonate, pH 11.5 andincubated for 30 min on ice. The sample was then adjusted to 1.6 M
sucrose, overlaid with a step gradient of 1.25 M- and 250 mM sucrose,
and centrifuged at 47,000 rpm for 2 h in an SW60.1 rotor (Beckman
Instruments). The gradient fractions containing soluble proteins (i.e.,
the bottom 1.6 M sucrose layer) andmembrane-inserted proteins (i.e.,
the 1.25 M sucrose layer plus 0.25–1.25 M sucrose interface) were
precipitated using trichloroacetic acid and analyzed by SDS-PAGE
followed by electrotransfer to HyBond P. Blots were probed with
antibodies against p13 (rabbit anti-p13, raised against the synthetic
protein), Porin (Calbiochem), and Hsp 60 (Santa Cruz) followed by
horseradish peroxidase-conjugated secondary antibodies (Pierce) and
developed with chemiluminescence detection reagents (Pierce Super-
signal Pico). Chemiluminescent signals were detected by exposure to
Hyperﬁlm (GE Healthcare) or with a BioRad ChemiDoc XRS imager.
Mitochondrial volume changes, membrane potential, ROS produc-
tion, and the threshold for opening of the permeability transition pore
(PTP) were measured in a PerkinElmer 650–40 spectroﬂuorimeter
equipped with magnetic stirring and thermostatic control. Mitochon-
drial volume changes were measured in “swelling assays” as the
change in 90° light scattering at 540 nm [13]. Membrane potential was
assayed by measuring the change in ﬂuorescence intensity of
rhodamine 123 (Molecular Probes) added at a concentration of
300 nM [14]. The probe was excited at 503 nm, and emission was
analyzed at 525 nmwith the excitation and emission slits set at 2 and
5 nm, respectively. O2 consumption was measured polarographically
with a Clark oxygen electrode in a closed temperature-controlled 2-ml
vessel equipped with magnetic stirring (Yellow Springs Instruments).
These assays were performed at 25 °C in a 2-ml ﬁnal volume
containing 2 mg mitochondria (measured as total protein in the
Biuret assay) and KCl buffer, pH 7.4 (125 mM KCl, 10 mM Tris-MOPS,
pH 7.4,1mMPi-Tris, 20 μMEGTA-Tris, 5mMglutamic acid and 2.5mM
malic acid).
Production of ROS in mitochondria was measured using Amplex
UltraRed (Molecular Probes), which reacts with H2O2 in a 1:1
stoichiometric ratio to produce the ﬂuorescent product Resoruﬁn.
Mitochondria (2 mg) were resuspended in KCl buffer in the presence
of 5 μM Amplex UltraRed reagent and 5 mg/ml horseradish
peroxidase. The probe was excited at 563 nm and its emission was
measured at 587 nm over a 5-min timeframe at 37 °C in the absence or
presence of p13 and other treatments described in the text. The slopes
(m) of the resulting traces were used to calculate changes in H2O2
production expressed as the ratio (m2/m1) wherem2 is the slope after
the treatment and m1 is the slope before the treatment.
The threshold for PTP opening was assessed by measuring the
mitochondrial calcium retention capacity using the Ca2+ indicator
Calcium Green-5N (Molecular Probes) as described previously [15].
For electron microscopy isolated mitochondria were ﬁxed over-
night at 4 °C in 3% glutaraldehyde prepared in 0.1 M sodium
cacodylate buffer (pH 6.9), post ﬁxed for 2 h in 1% osmium tetroxide
in the same buffer and then processed according to [16]. Ultrathin
sections (80 nm) were cut with an ultramicrotome (Ultracut,
Reichert-Jung, Wien, Austria), stained with lead citrate and observed
with a transmission electron microscope (TEM 300, Hitachi) operat-
ing at 75 kV.
3. Results
3.1. p13 increases the permeability of mitochondria to K+ and affects
their ultrastructure
Fig. 1 shows the effects of full-length p13 on mitochondrial light
scattering, a measure of mitochondrial shape and volume. Assays
performed in isotonic KCl buffer (125 mM KCl) conﬁrmed that p13
induced a dose-dependent change of mitochondrial light scattering,
and comparison with the p139–41 peptide employed in previous
studies indicates that full-length p13 was considerably more potent
Fig.1. Effects of p13 on K+ permeability; submitochondrial targeting of p13. Rat livermitochondria isolated as described in the text were placed in isotonic KCl buffer and treated with
synthetic p13 protein. (A) Comparison of the light scattering change induced by full-length p13 (circles) and by a peptide spanning the alpha helical region of the protein [(p139–41),
triangles]. Values on the ordinate refer to the difference in light scattering at 540 nm measured after the addition of p13. Full-length p13 was tested at 12.5, 25, 50, 100, 200, 400,
800 and 1600 nM; p139–41 was tested at 400, 800, 1600, 3200 and 5000 nM. (B) Assays were carried out as described for panel A using 100 nM full-length p13 with the KCl and
sucrose concentrations indicated on the abscissa. Values on the ordinate are scaled to a reference 100% light scattering change obtained in 125 mM KCl. (C) p13-induced changes of
light scattering were reverted upon addition of 100 nM FCCP, which conﬁrms their link to energy-dependent ion transport; in contrast, no effect on K+ permeability was obtained
with a p13mutant carrying substitutions in the 4 critical arginine residues in the alpha helical domain of the protein (p13-AL). Results are representative of at least 3 experiments for
each assay. Panel D shows results of digitonin and sodium carbonate extraction assays carried out to verify uptake of p13 into isolated mitochondria (see Materials and methods).
Immunoblots were probed with antibodies against the indicated proteins and analyzed by chemiluminescent imaging (Digitonin panel) or exposure to autoradiographic ﬁlm
(Carbonate panel). As described in the Results, these assays indicated that p13 accumulated mainly in the inner mitochondrial membrane.
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on the K+ concentration, we carried out experiments in isotonic
buffers containing increasing concentrations of K+. Fig. 1B demon-
strates that the effect induced by full-length p13 was strictly
dependent on the KCl concentration.
Interestingly, the effects obtained with concentrations of p13
ranging from 50 nM to 400 nM were reversed after treatment with
FCCP (Fig. 1C), a protonophore that collapses mitochondrial mem-
brane potential (Δψ). This ﬁnding is consistent with a Δψ-dependent
uptake of K+ and indicates that the permeability increase induced by
p13 is selective for K+ vs. H+ in this concentration range. In contrast,
higher p13 concentrations (0.8 and 1.6 μM) resulted in only partial
volume recovery after FCCP treatment (Fig. 1C), possibly reﬂecting a
loss of selectivity which might have resulted in the transport of Cl− as
well. Importantly, no light scattering changes were induced by the
p13-ALmutant (Fig. 1C, grey traces), which carries substitutions of the
4 arginine residues in the alpha helical domain with alanine and
leucine and is unable to induce mitochondrial morphological changes
in cells [10].
To interpret the effects of p13 on mitochondrial parameters it was
important to verify the uptake of synthetic p13 into isolated
mitochondria, and the site of its accumulation, i.e., in the outer
membrane, intermembrane space, matrix, or inner membrane, asdocumented previously for p13 expressed in transfected HeLa cells
[10]. For this purpose, rat liver mitochondriawere incubated with p13,
washed, and then incubated with DMSO (5%, serving as a control) or
digitonin (0.05% or 0.5%, prepared in DMSO). Resulting supernatants
and pellets were analyzed by SDS-PAGE and immunoblotting to detect
p13 and Porin, amarker for the outermitochondrial membrane, which
is expected to be solubilized by 0.5% digitonin. As shown Fig. 1D, a
strong p13 signal (bothmonomer andmultimer forms) was evident in
the pellet fraction of mitochondria treated with DMSO or 0.05%
digitonin. This observation veriﬁed that p13 was indeed taken up by
isolated rat liver mitochondria in our in vitro assays. Treatment with
0.5% digitonin extracted a substantial portion of Porin; in contrast, p13
was detected almost exclusively in the pellet after this extraction. This
result allowed us to exclude the outer membrane as the site of p13
accumulation.
To determine whether p13 taken up by mitochondria was
membrane-inserted, which would indicate its accumulation in the
inner membrane rather than the matrix or intermembrane space, we
subjected p13-loaded mitochondria to sodium carbonate extraction
[10]. Resulting fractions containing membrane-integrated proteins
and soluble proteins were immunoblotted to detect p13 and Hsp 60 (a
marker for a soluble mitochondrial protein). As shown in Fig. 1D, Hsp
60 was present mainly in the soluble fraction after carbonate
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fraction (as a multimer on this blot). Interpretation of these results
together with those of the digitonin assay led us to conclude that p13
accumulated mainly in the inner mitochondrial membrane in our in
vitro assays.
To gain insight into the basis for the light scattering changes
induced by p13, we compared the ultrastructure of mitochondria
subjected to treatment with p13 to that of mitochondria swollen
through Ca2+ mediated PTP opening. Results shown in Fig. 2 indicate
that 100 nM p13 induced a shape change in mitochondria resulting in
an electron-dense ring- or crescent-like morphology (Fig. 2C) that
was clearly different from the large-amplitude swelling triggered by
Ca2+ (Fig. 2B), suggesting that the two processes leading to
membrane permeabilization are distinct (see Discussion). Interest-
ingly, in analogy with results observed in the light scattering assay
(Fig. 1C), treatment with 100 nM p13 followed by FCCP resulted in a
recovery of the original mitochondrial ultrastructure (Fig. 2D),
suggesting that the basis for the shape changes was linked to
energy-dependent K+ transport. As shown in Fig. 2E, treatment with
800 nM p13, which triggered swelling that was only partially
reversed by FCCP (see Fig. 1C), resulted in a substantial proportion
of mitochondria that exhibited large-amplitude swelling similar to
that observed using Ca2+.
3.2. p13 inﬂuences mitochondrial membrane potential and electron
transport chain (ETC) activity
If the process of K+ inﬂux induced by p13 is electrophoretic, it
should cause inner membrane depolarization. This was tested usingFig. 2. Effects of p13 onmitochondrial ultrastructure. Results show the ring/crescent-like mo
swelling induced by Ca2+ through PTP opening (B) or high doses of p13 (E). Effects of 100rhodamine 123, which is taken up by energized mitochondria in a
potential-dependent manner [14]. Fig. 3A shows that p13 induced
depolarization, with a marginal effect seen at low concentrations (50,
100 nM) and progressively more potent effects at higher concentra-
tions (e.g. 1.6 μM) that nearly equaled the depolarization induced by
FCCP. Interestingly, the p13-AL mutant had no effect on Δψ (Fig. 3A).
Electron transport through the ETC is coupled to proton extrusion.
Therefore, membrane depolarization is predicted to stimulate electron
transport and increase O2 consumption. Closed-chamber polaro-
graphic measurements showed that p13 induced a dose-dependent
increase in O2 consumption when added up to a concentration of
400 nM (Fig. 3B). This effect leveled off at higher p13 concentrations,
suggesting that other mitochondrial alterations might ensue, e.g.
release of pyridine nucleotides or cytochrome c, which may result
from swelling and outer membrane rupture [17]. This hypothesis is
consistent with the reduced selectivity of the membrane permeability
changes induced by p13 at high concentrations (see results in Fig. 1C).
In analogy with its lack of permeabilizing activity in other assays, the
p13-AL mutant did not affect O2 consumption, nor did wild-type p13
when assayed in sucrose-based buffer lacking K+, underscoring the
strict K+-selectivity of this effect.
We next tested whether increased proton extrusion resulting from
the activation of the ETC might partially dampen p13′s effects on Δψ
(Fig. 3C). To this end, we exposed mitochondria to rotenone, which
blocks complex I of the ETC. As expected, rotenone induced partial
depolarization. Pretreatment with p13 at 12.5 nM, i.e. a concentration
unable to induce measurable depolarization per se, substantially
increased rotenone-induced depolarization. This effect was more
pronounced at 50 nM p13, which in the presence of rotenone inducedrphology of mitochondria treated with 100 nM p13 (C) in comparison to large amplitude
nM p13 on ultrastructure were reverted by FCCP (D).
Fig. 3. Effects of p13 on mitochondrial membrane potential, respiration and ROS. (A) Effects of p13 on mitochondrial membrane potential. Depolarization is reported on the y axis as
the change in rhodamine 123 ﬂuorescence expressed as the percentage of the depolarization induced by 100 nM FCCP (set as 100%). (B) Effects of p13 on mitochondrial O2
consumption. The y axis reports the fold change in the rate of O2 consumption compared to the basal rate recorded in the absence of p13. (C) Inhibition of the ETC by rotenone
enhances the depolarizing effects of p13. Depolarization is reported on the y axis as in panel A. The additive effect of the p13-induced depolarization and ETC inhibition by 2 μM
rotenone is particularly evident at low concentrations of p13 that do not induce measurable depolarization per se. (D) Effects of p13 onmitochondrial H2O2, measured with the probe
Amplex UltraRed. The y axis reports the ratiom2/m1, wherem2 andm1 are the slopes of the traces after and before the indicated treatment, respectively. Results are representative of
at least 3 experiments for each assay.
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thus indicate that even low concentrations of p13 induce permeabi-
lization to K+ whose consequences on membrane potential and
respiration fully emerge upon inhibition of the ETC.
3.3. Effects of p13 on ROS
As the ETC is a major source of ROS production in mitochondria,
and since the amount of ROS produced depends on the rate of electron
ﬂux and the membrane potential, we reasoned that modulation of
respiratory chain activity by p13might be accompanied by a change in
the levels of mitochondrial ROS. This possibility was tested using the
H2O2 probe Amplex UltraRed. Fig. 3D reports the changes in probe
ﬂuorescence produced by different treatments, calculated as the ratio
of the slopes after and before the treatment (see Materials and
methods). Results showed that p13 induced a dose-dependent
increase in ROS production (Fig. 3D). Interestingly, a similar effect
was induced by the K+ ionophore valinomycin. In contrast, treatmentwith FCCP reduced H2O2 production, suggesting that depolarization
induced by H+ vs. K+ currents has opposite effects on ROS (see
Discussion). Consistent with its dependence on K+ transport, H2O2
production was not observed with the p13-AL mutant (Fig. 3D).
It is known that monoamine oxidases (MAO) associated with the
outer mitochondrial membrane are also an important source of ROS in
mitochondria [18]. To speciﬁcally measure H2O2 originating from the
ETC we inhibited MAO activity using pargyline. Although this
treatment did decrease the overall ﬂuorescence intensity, p13 was
still able to increase probe's ﬂuorescence, indicating that its effects on
ROS are independent of MAO activity (data not shown).
3.4. Effects of p13 on PTP gating
Both mitochondrial depolarization [19] and ROS [20] are known to
affect the probability of opening of the PTP, a large conductance
mitochondrial channel that triggers cell death through energy
shortage and release of proapoptotic factors localized in the
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opening we employed the Ca2+ retention capacity assay (see
Materials and methods and ref [15]). This assay measures the
sensitivity of the PTP to opening in response to Ca2+, which is rapidly
taken up by energized mitochondria. Uptake and release of Ca2+ by
mitochondria is measured using Calcium Green, a Ca2+ probe that is
excluded from mitochondria and therefore ﬂuoresces when Ca2+ is
present outside mitochondria. Fig. 4A shows that addition of Ca2+
resulted in its rapid uptake by mitochondria. The mitochondria were
able to retain this dose of Ca2+ until PTP opening was triggered by
depolarization with FCCP (see trace in Fig. 4A) [23]. Remarkably,
400 nM p13 was also able to trigger PTP opening; in contrast, the p13-
AL mutant had no effect. Further experiments carried out with serial
additions of Ca2+ allowed us to estimate the sensitivity of the PTP
based on the concentration of Ca2+ required to open it. Fig. 4B shows
results of this analysis, expressed as the Ca2+ retention capacity (CRC),
which demonstrated that p13 reduced the CRC of mitochondria in a
dose-dependentmanner, indicating that the proteinmay indeed affectFig. 4. Effects of p13 on the opening threshold of the PTP. Effects of p13 on PTP opening were
text and ref. [15]). The same KCl isotonic incubation medium described for other in vitro
experiment of Ca2+ uptake and release following stimuli that trigger PTP opening. Panels B a
with increasing doses of p13 (B) and inhibition by CsA or ROS scavengers (C). RFU, relativethe threshold for PTP opening. Interestingly, treatment with the ROS
scavengermercaptopropionylglycine (MPG) partly inhibited the effect
of p13, suggesting that the latter is, at least in part, ROS-dependent
(Fig. 4C). Treatment of mitochondria with CsA resulted in an increase
in CRC both in control and p13-treated mitochondria (Fig. 4C).
4. Discussion
The observations made in the present study support the working
model of p13 function illustrated in Fig. 5. We have demonstrated that
(i) p13 triggers an inward K+ current into mitochondria (Fig. 1),
ultrastructural changes (Fig. 2) and depolarization (Fig. 3A); (ii)
depolarization induced by p13 enhances respiratory chain activity
(Fig. 3B), which in turn partially dampens depolarization by
increasing H+ extrusion (Fig. 3C); (iii) these changes are accompanied
by increased production of ROS (Fig. 3D)which, alongwithmembrane
depolarization, may (iv) be responsible for lowering the threshold of
PTP opening (Fig. 4).assessed by measuring the Ca2+ retention capacity (CRC) of isolated mitochondria (see
assays was supplemented with 1 μM Calcium Green-5N. Panel A shows a time course
nd C show the Ca2+ concentration required to trigger PTP opening following treatment
ﬂuorescence units. CRC, Ca2+ retention capacity.
Fig. 5. Working model of p13 function. p13 forms or affects a K+ channel in the inner
mitochondrial membrane (IM) leading to K+ inﬂux in energized mitochondria. This
induces depolarization that is partly compensated by activation of the respiratory chain
and consequent increased extrusion of H+. However, ETC activity also increases matrix
pH and the chemical H+ gradient, resulting in increased ROS production which, along
with membrane depolarization, may lower the opening threshold of the PTP and trigger
cell death. Increased H2O2 levels may also engage ROS-dependent “extramitochondrial”
cell death pathways (e.g. ASK1/p38).
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channel-forming activity or affects the activity of one of the described
endogenous K+ channels [24]. The ﬁrst possibility is suggested by the
previously documented ability of p13 to formmultimeric structures in
lipid-like environments [10], a property that has been described for
channel-forming proteins termed viroporins that are coded by several
other viruses [25].
A study by Hackenbrock [26] demonstrated a tight link between
mitochondrial ultrastructure (and light scattering properties) and the
oxidative phosphorylation/electron transport state as deﬁned by
Chance and Williams [27]. In contrast to large amplitude osmotic
swelling which leads to outer membrane rupture, cristae unfolding,
marked matrix expansion and loss of mitochondrial structure and
function, the ultrastructural changes accompanying shifts in meta-
bolic state are of smaller amplitude, and readily reversible. The most
dramatic “state-coupled” change was observed in the state IV to state
III transition in which ETC activity is dramatically boosted by addition
of ADP in the presence of substrates. In this condition, Hackenbrock
observed that the matrix condensed in a peripheral eccentric or ring-
like structure surrounding an “internal compartment” apparently
connected to the intermembrane space [26]. Interestingly, these
ultrastructural changes and their reversibility closely match our
observations made with low (e.g. 100 nM) concentrations of p13,
suggesting that the ultrastructural changes induced by p13 are likely
to result from a boost in ETC activity triggered by the inward K+
current.
The ﬁnding that p13 triggers depolarization and increases ROS
balance in isolated mitochondria may appear to be in contrast with
previous studies suggesting that a decreased proton electrochemical
gradient due to increased electron ﬂux should be accompanied by
reduced diversion of electrons from the ETC to oxygen, which should
in turn result in decreased ROS production [28]. It is important to note
that the data on which these conclusions are based were obtained
either with the addition of protonophores or with activation of
uncoupling proteins, i.e. under conditions where the depolarizing
charge is carried by H+, which will also cause matrix acidiﬁcation and
substrate depletion. In our studies the depolarizing current is carried
by K+, which causes a compensatory increase in H+ pumping and will
tend to increase matrix pH. Consistent with a key difference between
depolarization by H+ and K+ currents, the effect of p13 on ROSproductionwasmimicked by the K+-selective ionophore valinomycin,
while treatment with the protonophore FCCP resulted in the expected
decrease in H2O2 production (Fig. 3D). Our ﬁndings are also consistent
with recent data of Costa et al. showing that opening of the
mitochondrial KATP channel results in matrix alkalinization and
increased H2O2 production [29].
Interestingly, mitochondrial generation of H2O2 was also demon-
strated to occur during ceramide-induced apoptosis [30], a ﬁnding that
suggests a link between the present work and previous results showing
that expression of p13 in HeLa and Jurkat T cells was associated with an
increased sensitivity to apoptosis induced by ceramide [7,8].
As shown in Fig. 4, p13 modulates the PTP and increases its
sensitivity to opening. This effect can be traced to two synergistic
mechanisms, i.e. (i) ROS-mediated shifting of the PTP voltage
threshold [31], which is consistent with the recent demonstration
that the pore plays a key role in the production of superoxide ﬂashes
in situ [32], and (ii) lowering of the membrane potential, which would
draw the resting potential nearer to the opening threshold [33] (see
[34] for a recent review on the relationship betweenmitochondrial K+
channels and PTP regulation).
The ability of p13 to slow down cell growth [8] and sensitize cells
to the apoptotic stimuli FasL and ceramide [7,8] suggests that this
protein might limit the transforming potential of HTLV-1 in infected
cells. This possibility is intriguing in light of the fact that Tax, themajor
HTLV-1-encoded oncoprotein, protects cells from apoptosis induced
by mitochondria-mediated death stimuli [35,36]. Therefore Tax and
p13 might exert opposite effects on cell turnover, on the one hand
expanding the pool of infected cells and on the other hand limiting
neoplastic transformation, thus favoring viral persistence and adapta-
tion to the host. This hypothesis is consistent with the low frequency
and long clinical latency of ATLL and with results of experiments
carried out in a rabbit experimental model showing that p13 is
required to establish a persistent infection in vivo [9]. Through its
stimulation of ROS, p13 could also affect redox-sensitive gene
expression, the consequences of which could either favor cell survival
or promote cell death.
The accumulated data describing p13's biological properties
reinforce the emerging concept that manipulation of mitochondrial
function is a key point of convergence in tumor virus replication
strategies. Indeed, recent studies have revealed that many viruses,
including all of the human tumor viruses, express mitochondrial
proteins [37,38]. Further investigations of p13 and its interactions with
mitochondria may thus provide important insights into the mechan-
isms of HTLV-1 replication and pathogenesis and could aid in the
discovery of new targets for anti-tumor therapy.
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